Last reviewed · How we verify
PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM
PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM is a Small molecule drug developed by HaEmek Medical Center, Israel. It is currently in Phase 1 development.
At a glance
| Generic name | PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM |
|---|---|
| Sponsor | HaEmek Medical Center, Israel |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Role of Prophylactic Postoperative Antibiotics in HoLEP (PHASE4)
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (PHASE3)
- Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder (PHASE4)
- Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections (PHASE2)
- Antibiotics for Kidney Transplant Recipients (PHASE4)
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) (PHASE2, PHASE3)
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) (PHASE2, PHASE3)
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM CI brief — competitive landscape report
- PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM updates RSS · CI watch RSS
- HaEmek Medical Center, Israel portfolio CI
Frequently asked questions about PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM
What is PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM?
PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM is a Small molecule drug developed by HaEmek Medical Center, Israel.
Who makes PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM?
PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM is developed by HaEmek Medical Center, Israel (see full HaEmek Medical Center, Israel pipeline at /company/haemek-medical-center-israel).
What development phase is PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM in?
PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM is in Phase 1.